$39.36 0.82 (+2.13%)
11/23/2009 4:00 PM

Vertex Pharmaceuticals, Inc. (VRTX)

CAPS Rating: 2 out of 5

The Company is in the business of discovering, developing and commercializing small molecule drugs for the treatment of serious diseases.

Featured Broker Partners